These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 31444656)

  • 1. Development and validation of a new prediction model for graft function using preoperative marginal factors in living-donor kidney transplantation.
    Matsukuma Y; Masutani K; Tanaka S; Tsuchimoto A; Nakano T; Okabe Y; Kakuta Y; Okumi M; Tsuruya K; Nakamura M; Kitazono T; Tanabe K;
    Clin Exp Nephrol; 2019 Nov; 23(11):1331-1340. PubMed ID: 31444656
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tubular Cell Senescence in the Donated Kidney Predicts Allograft Function, but Not Donor Remnant Kidney Function, in Living Donor Kidney Transplantation.
    Sofue T; Kushida Y; Ozaki T; Moritoki M; Nishijima Y; Ohsaki H; Ueda N; Kakehi Y; Nishiyama A; Minamino T
    Am J Nephrol; 2018; 47(1):8-17. PubMed ID: 29275400
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and validation of a risk score for the prediction of cardiovascular disease in living donor kidney transplant recipients.
    Ueki K; Tsuchimoto A; Matsukuma Y; Nakagawa K; Tsujikawa H; Masutani K; Tanaka S; Kaku K; Noguchi H; Okabe Y; Unagami K; Kakuta Y; Okumi M; Nakamura M; Tsuruya K; Nakano T; Tanabe K; Kitazono T;
    Nephrol Dial Transplant; 2021 Jan; 36(2):365-374. PubMed ID: 33367750
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety and Effectiveness of Marginal Donor in Living Kidney Transplantation.
    Oikawa M; Hatakeyama S; Narita T; Yamamoto H; Hosogoe S; Imai A; Yoneyama T; Hashimoto Y; Koie T; Fujita T; Murakami R; Saitoh H; Funyu T; Narumi S; Ohyama C
    Transplant Proc; 2016 Apr; 48(3):701-5. PubMed ID: 27234717
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Living Kidney Transplantation From Marginal Donors Presents Feasible Donor Renal Function Despite Inferior Recipient Renal Function.
    Hamano I; Hatakeyama S; Fujita T; Murakami R; Hamaya T; Togashi K; Suzuki Y; Yamamoto H; Yoneyama T; Yoneyama T; Hashimoto Y; Narumi S; Tomita H; Ohyama C
    Transplant Proc; 2020; 52(6):1723-1728. PubMed ID: 32448670
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of donor-recipient body surface area ratio on donor age and donor glomerular filtration rate in Chinese patients undergoing a living-donor kidney transplant.
    Lv J; Guga S; Huang H; Wang R; Zhang X; Shou Z; Chen J; Wu J
    Exp Clin Transplant; 2014 Dec; 12(6):515-21. PubMed ID: 25019250
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical and pathological features of donor/recipient body weight mismatch after kidney transplantation.
    Yamakawa T; Kobayashi A; Yamamoto I; Nakada Y; Mafune A; Katsumata H; Furuya M; Koike K; Miki J; Yamada H; Tanno Y; Ohkido I; Tsuboi N; Yokoyama K; Yamamoto H; Yokoo T
    Nephrology (Carlton); 2015 Jul; 20 Suppl 2():36-9. PubMed ID: 26031584
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Living donor kidney transplants: a biopsy study 1 year after transplantation, compared with baseline changes and correlation to kidney function at 1 and 3 years.
    Sund S; Reisaeter AV; Fauchald P; Bentdal O; Hall KS; Hovig T
    Nephrol Dial Transplant; 1999 Oct; 14(10):2445-54. PubMed ID: 10528671
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pre-existing arteriosclerotic intimal thickening in living-donor kidneys reflects allograft function.
    Sofue T; Inui M; Kiyomoto H; Moritoki M; Nishioka S; Nishijima Y; Moriwaki K; Hara T; Kushida Y; Haba R; Yoda T; Hirao T; Kakehi Y; Nishiyama A; Kohno M
    Am J Nephrol; 2012; 36(2):127-35. PubMed ID: 22797609
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Graft failure of IgA nephropathy in renal allografts following living donor transplantation: predictive factor analysis of 102 biopsies.
    Zhang J; Chen GD; Qiu J; Liu GC; Chen LZ; Fu K; Wu ZX
    BMC Nephrol; 2019 Dec; 20(1):446. PubMed ID: 31796001
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of time-zero biopsy on early graft outcomes after living donor kidney transplantation.
    Lee AL; Kim YS; Lim BJ; Jeong HJ; Joo DJ; Kim MS; Huh KH
    Transplant Proc; 2013 Oct; 45(8):2937-40. PubMed ID: 24157007
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Follow-up After Donor Nephrectomy in Living Kidney Donors: How to Manage Living Kidney Donors Postoperatively.
    Hori S; Tomizawa M; Inoue K; Yoneda T; Nakahama T; Onishi K; Morizawa Y; Gotoh D; Nakai Y; Miyake M; Torimoto K; Tanaka N; Fujimoto K
    In Vivo; 2024; 38(4):1900-1910. PubMed ID: 38936934
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of patients at risk for renal impairment after living donor kidney transplantation.
    Kaltenborn A; Nolte A; Schwager Y; Littbarski SA; Emmanouilidis N; Arelin V; Klempnauer J; Schrem H
    Langenbecks Arch Surg; 2016 Dec; 401(8):1219-1229. PubMed ID: 27502290
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factors of impact on graft function at 2 years after transplantation in living-donor kidney transplantation: a single-center study in china.
    Zhao J; Song WL; Mo CB; Wang ZP; Fu YX; Feng G; Zheng JM; Shen ZY
    Transplant Proc; 2011 Dec; 43(10):3690-3. PubMed ID: 22172827
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prediction model of compensation for contralateral kidney after living-donor donation.
    Okumura K; Yamanaga S; Tanaka K; Kinoshita K; Kaba A; Fujii M; Ogata M; Hidaka Y; Toyoda M; Uekihara S; Miyata A; Inadome A; Yokomizo H
    BMC Nephrol; 2019 Jul; 20(1):283. PubMed ID: 31349815
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of baseline histopathology and kidney donor risk index with graft outcomes in deceased donor kidney transplantation
.
    Park KS; Park SJ; Park H; Kim M; Park J; Chung HC; Cho HR; Lee JS
    Clin Nephrol; 2019 Jun; 91(6):363-369. PubMed ID: 30848240
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of donor/recipient body weight ratio, donor weight, recipient weight and donor age on kidney graft function in children.
    Špatenka J; Seeman T; Foltynová E; Burkert J; Dušek J; Vondrák K; Janda J; Habrmanová A; Krejčová J; Matoušovic K
    Nephrol Dial Transplant; 2012 Feb; 27(2):820-4. PubMed ID: 21652544
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A simple clinico-histopathological composite scoring system is highly predictive of graft outcomes in marginal donors.
    Anglicheau D; Loupy A; Lefaucheur C; Pessione F; Létourneau I; Côté I; Gaha K; Noël LH; Patey N; Droz D; Martinez F; Zuber J; Glotz D; Thervet E; Legendre C
    Am J Transplant; 2008 Nov; 8(11):2325-34. PubMed ID: 18785957
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Calcineurin inhibitor conversion to rapamycin can improve graft function in living donor kidney transplantation with older donors.
    Chen GD; Liu XC; Shi L; Qiu J; Wang CX; Fei JG; Li J; Huang G; Chen LZ
    Transplant Proc; 2013 May; 45(4):1648-50. PubMed ID: 23726640
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preoperative renal volumes as a predictor of graft function in living donor transplantation.
    Saxena AB; Busque S; Arjane P; Myers BD; Tan JC
    Am J Kidney Dis; 2004 Nov; 44(5):877-85. PubMed ID: 15492954
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.